The largest database of trusted experimental protocols

107 protocols using massarray platform

1

Genotyping and Haplotype Analysis of Gambian IFNG Loci

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotypes were determined on whole-genome amplified DNA (primer extension pre-amplification) by the Agena Bioscience MassArray platform (formerly SEQUENOM) using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry as previously described
25 (link). Details of the primer sequences and assays are given in
Extended datafiles 1 and
229 (link). The most informative haplotype-tagging SNPs (htSNPs) to type in Gambian subjects were identified by analysing the pattern of linkage disequilibrium (LD) in the
IFNG gene loci using previously available data from 32 Gambian family trios
25 (link),
30 (link)
. The PHASE program (
http://stephenslab.uchicago.edu/software.html) version 2.1 was used to infer haplotypes from the genotypes of the study population and estimate the frequency of each inferred haplotype
31 (link). The entropy maximization method was used to identify htSNPs that described >90% of the observed haplotypic diversity in this gene region
30 (link). The HaploXT program (
http://www.sph.umich.edu/csg/abecasis/GOLD/docs/haploxt.html) was used to estimate pairwise LD statistics. Sickle cell (HbS, rs334) and glucose-6-phosphate deficiency (G6PD) deficiency (rs1050828 and rs1050829) were also genotyped using the Agena Bioscience MassArray platform.
+ Open protocol
+ Expand
2

Genotyping of IL-6 Gene Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Based on previous studies [20 (link), 21 (link)], 1000 Genomes Chinese Han Beijing population and dbSNP database (https://www.ncbi.nlm.nih.gov/snp/) with a minor allele frequency (MAF) > 0.01, and Hardy–Weinberg equilibrium (HWE) > 0.05, we selected rs2069837 and rs13306435 in IL-6 gene for genotyping. Genomic DNA was extracted from peripheral blood samples using the GoldMag DNA Extraction Kit (GoldMag Co. Ltd, Xi’an, China). The concentration and purity of DNA were assessed using the NanDrop 2000 (Thermo Scientific, USA).
The primer sequence of rs2069837 and rs13306435 was presented in Additional file 1: Table S1. PCR reactions were performed in a buffer containing 1 μl DNA, 0.5 μl PCR Buffer, 0.4 μl MgCl2, 0.1 μl dNTP Mix, 1.0 μl primer mix, and 0.2 μl Taq ligase in a final reaction volume of 5 μl. The reaction mixture was heated to 94 °C for 15 min for denaturation. Then, the sample was subjected to 45 cycles of 94 °C 20 s, annealing at 56 °C 30 s and extension at 72 °C 60 s, followed by a final extension step at 72 °C for 3 min. The PCR product was used to genotype using the Agena MassArray platform (Agena Bioscience, San Diego, CA, USA) [21 (link), 22 (link)]. Then, the raw data was analyzed and managed using the Agena Typer 4.0 software.
+ Open protocol
+ Expand
3

Genotyping of CYP19A1 and CYP1A2 SNPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA extraction was performed on the basis of the manufacturer’s procedures of GoldMag Beads DNA Extraction Kit (GoldMag, Xi’an, Shaanxi, China). DNA concentration was determined by Spectrometry (Beckman Instruments, Fullerton, CA, USA). Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA) was utilized for SNP genotyping. The design of extended primers was conducted by the Agena online design software (https://agenacx.com/online-tools/), and the sequences were listed in Supplementary Table 1. The process of genotyping was double-blinded by two laboratory personnel. For quality control, 10% of the samples were randomly chosen for repeated genotyping, and the reproducibility was 100%.
All seven candidate SNPs in CYP19A1 (rs4646, rs6493487, rs1062033, rs17601876 and rs3751599) and CYP1A2 (rs762551 and rs2470890) were screened using the database of dbSNP in NCBI and the 1000 Genomes Project data, and the selection criteria were as follows: i) the minor allele frequency (MAF) of all SNPs was greater than 5%; ii) call rate was over 95% during genotyping; iii) r2, a pairwise linkage disequilibrium (LD), was over 0.8. Besides, we applied RegulomeDB annotations to predict the effect of these SNPs according to the rank score evaluated by a model integrating functional genomic features.
+ Open protocol
+ Expand
4

Genetic Variants in PTGER4 and PRKAA1 Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The physical location of the PTGER4 and PRKAA1 genes was searched using NCBI database (https://www.ncbi.nlm.nih.gov/gene/). SNPs within 500 kb of PTGER4 and PRKAA1 genes with minor allele frequency (MAF) > 0.05, Hardy-Weinberg equilibrium (HWE) > 0.05, min genotype frequency > 75%, and r2 > 0.8 in the Chinese Han Beijing (CHB) population of 1000 Genome Project were screened using the VCF to PED Converter window (http://grch37.ensembl.org/HomoSapiens/Tools/VcftoPed) and Haploview software. Finally, Based on primer design and genotyping results, a total of nine SNPs (rs4613763, rs6880778, rs11742570, rs9292777, rs7725052, rs12186979, and rs10036575 in PTGER4, rs10074991 and rs13361707 in PRKAA1) were chosen for the association analysis. The functional annotation of SNPs was predicted using the Regulomedb database (https://regulomedb.org/). Peripheral blood genomic DNA was extracted using GoldMag DNA Purification Kit (GoldMag Co. Ltd.). The concentration and purity of DNA are detected using NanoDrop 2000 (Thermo Scientific). The Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA) was used for SNPs genotyping. AgenaTyper 4.0 software was used to organize and analyze genotype data.
+ Open protocol
+ Expand
5

FNDC1 Genetic Variant Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
First of all, three variants of FNDC1 (rs420137, rs386360, and rs7763726) were selected from the HapMap database according to the minor allele frequency (MAF) >5% and the unbalanced r2 value >0.8. Then, we genotyped them by the Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA). Finally, the results of genotyping were processed and analyzed by Agena Bioscience Typer software (version 4.0).
+ Open protocol
+ Expand
6

Genotyping of ACYP2 SNPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twelve SNPs (rs6713088, rs12621038, rs1682111, rs843752, rs10439478, rs843645, rs11125529, rs12615793, rs843711, rs11896604, rs17045754, and rs843720) in ACYP2 screened in previous research (Chen et al., 2016; Chen et al., 2017; Fang et al., 2016; He et al., 2016; Li et al., 2017; Liang et al., 2016; Liu et al., 2016; Zhang et al., 2016) at a minor allele frequency (MAF) > 5% in the global population were examined in our study. The amplification and extension SNP primers were designed using the Agena Bioscience Assay Design Suite V2.0 software (https://agenacx.com/online-tools/). The sequences of primers corresponding to each SNP are shown in Table 1. These polymorphisms were genotyped using the Agena MassARRAY platform with iPLEX gold chemistry (Agena Bioscience) according to the standard protocol recommended by the manufacturer. Agena Bioscience TYPER version 4.0 software was used for data management and analysis.
+ Open protocol
+ Expand
7

Genotyping of CYP4F2 SNPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study, five SNPs (rs3093203, rs3093144, rs12459936, rs3093110, and rs3093193) in CYP4F2 were selected according to previously published studies on the association between CYP4F2 polymorphisms and disease susceptibility (12 (link)–14 (link)). The genotype distributions of the candidate SNPs in controls met Hardy–Weinberg equilibrium (HWE) (p >0.05). All the candidate SNPs had a minor allele frequency (MAF) of >5% in the Han Chinese in Beijing (CHB) population from the 1,000 Genomes Project (http://www.internationalgenome.org/). The primers for five SNPs were designed by Agena Bioscience Assay Design Suite version 2.0 software. The polymorphisms were genotyped using the Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA) with iPLEX gold chemistry. Ultimately, Agena Bioscience TYPER version 4.0 software was used for data management and genotyping result analysis.
+ Open protocol
+ Expand
8

Genetic Variants and Rheumatoid Arthritis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five whole blood samples were available from each participants. According to the manufacturer’s instructions, genomic DNA was extracted from whole blood samples using the GoldMag-Mini Whole Blood Genomic DNA Purification Kit (GoldMag. Co. Ltd., Xi’an, China). The DNA concentration and purity were assessed using spectrophotometer (NanoDrop 2000; Thermo Fisher Scientific, Waltham, MA, USA). In this study, FCRL1 rs2050568, FCRL3rs2317230, and FCRL6 rs58240276 were chose to investigate the influence on the risk of RA from the 1000 Genomes Project (http://www.1000genomes.org/) with the minor allele frequency (MAF) > 5% [18 (link)]. The amplification and extension primers were performed through the Agena Bioscience Assay Design Suite V2.0 software (https://agenacx.com/online-tools/), following the guideline. Subsequently, SNPs genotyping and data analysis were conducted using the Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA) and Agena Bioscience TYPER version 4.0, respectively.
+ Open protocol
+ Expand
9

Genotyping of ST6GAL1 and CYP19A1 SNPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
We identified two SNPs (rs2239611, rs1042757) in ST6GAL1 and two SNPs (rs2255192, rs4646) in CYP19A1 with a minor allele frequency (MAF) ≥ 5% of the 1000 Genomes Project Data. The DNA was extracted from peripheral blood using the DNA purification kit (GoldMag Co. Ltd., Xi’an, China). The concentration and purity of DNA were measured using the NanoDrop 2000 (Thermo Scientific, Waltham, MA, USA). Genotyping of ST6GAL1 and CYP19A1 were performed by the Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA) as described in previous studies [15 (link)]. MassARRAY Typer 4.0 software was used for data management and analysis.
+ Open protocol
+ Expand
10

IL-1R2 Genetic Variant Genotyping in Peripheral Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected 5ml peripheral blood samples from each subject using venipuncture into ethylene diamine tetraacetic acid (EDTA)‐coated blood vacutainer collection tubes and then stored at −80°C for further use. We used the GoldMag‐Mini Whole Blood Genomic DNA Purification Kit (GoldMag. Co. Ltd., Xi'an, China) to extract genomic DNA from blood samples following the manufacturer's instructions. We assessed the purity and concentration of the extracted DNA using a spectrophotometer (NanoDrop 2000; Thermo Fisher Scientific, Waltham, MA) by absorbance measurements at 260 and 280 nm.
Six SNPs (rs11674595, rs4851527, rs719250, rs3218896, rs3218977, and rs2072472) in IL‐1R2 with minor allele frequency (MAF) greater than 0.05 in the global population from the HapMap database and previously reported were adopted for analysis. We used the Agena Bioscience Assay Design Suite V2.0 software (https://agenacx.com/online-tools/) to design the primers of PCR amplification and extension of the six selected SNPs. These SNPs in IL‐1R2 were genotyped in the case and control groups using the Agena MassARRAY platform with iPLEX gold chemistry (Agena Bioscience, San Diego, CA) according to the manufacture's instructions. We used the Agena Bioscience TYPER software (version 4.0) to manage and analyze data.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!